Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

15.88

+0.23 (1.47%)

Jan 27, 2026, 11:23 AM EST - Market open

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Pharmaceutical	1.41M	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Growth	-58.15%	Log In	Log In	Log In	Log In	Upgrade
License and Other	516.00K	Log In	Log In	Log In	Log In	Upgrade
License and Other Growth	-96.49%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
United States	1.92M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-89.34%	Log In	Log In	Log In	Log In	Upgrade